Adasuve: FDA Approves First Inhaled Treatment For Schizophrenia And Bipolar Disorder
Category: WELLNESS
Dec 21 (Reuters) - Alexza Pharmaceuticals Inc said the U.S. health regulators approved Adasuve, making it the first treatment
By Reuters, Reuters, 2012-12-21